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Activation of the NF-κB pathway as a mechanism
of alcohol enhanced progression and metastasis
of human hepatocellular carcinoma
Fei Wang1,3†, Jin-Lian Yang1†, Ke-ke Yu1†, Mei Xu1,2, You-zhi Xu1, Li Chen1, Yan-min Lu1, Hao-shu Fang1,
Xin-yi Wang1,4, Zhong-qian Hu1, Fei-fei Li1, Lixin Kan1, Jia Luo1,2* and Si-Ying Wang1*
Abstract
Background: Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the third leading
cause of cancer-related death in human. Alcohol is a known risk factor for HCC. However it is still unclear whether
and how alcohol enhances the progression and metastasis of existing HCC.
Methods and results: We first retrospectively investigated 52 HCC patients (24 alcohol-drinkers and 28 non-drinkers),
and found a positive correlation between alcohol consumption and advanced Tumor-Node-Metastasis (TNM) stages,
higher vessel invasion and poorer prognosis. In vitro and in vivo experiments further indicated that alcohol promoted
the progression and migration/invasion of HCC. Specifically, in a 3-D tumor/endothelial co-culture system, we found
that alcohol enhanced the migration/invasion of HepG2 cells and increased tumor angiogenesis. Consistently, higher
expression of VEGF, MCP-1 and NF-κB was observed in HCC tissues of alcohol-drinkers. Alcohol induced the accumulation
of intracellular reactive oxygen species (ROS) and the activation of NF-κB signaling in HepG2 cells. Conversely, blockage
of alcohol-mediated ROS accumulation and NF-κB signaling inhibited alcohol-induced expression of VEGF and MCP-1,
the tumor growth, angiogenesis and metastasis.
Conclusion: This study suggested that chronic moderate alcohol consumption may promote the progression
and metastasis of HCC; the oncogenic effect may be at least partially mediated by the ROS accumulation and
NF-ĸB-dependent VEGF and MCP-1 up-regulation.
Keywords: Alcohol, Angiogenesis, Human hepatocellular cancer, Metastasis, Reactive oxygen species
Background
Hepatocellular carcinoma (HCC) is the most common
primary liver cancer and accounts for up to 70-85% of
primary liver cancers [1]. Advanced HCC carries a poor
prognosis with a five-year survival rate <10% [2]. It is
well recognized that both genetic and environmental fac-
tors contribute to human HCC. Alcohol, an important en-
vironmental factor, was classified as a group I carcinogen
and chronic alcohol consumption has been recognized as
an important risk factor for liver cancers [3,4]. In addition
to act as risk factor for carcinogenesis, epidemiological
studies also indicated that alcohol consumption is often
associated with advanced and aggressive tumors [5]. Al-
though alcohol is clearly recognized as a risk factor for
liver cancers, its role in cancer progression and metasta-
sis is currently unknown. We specifically hypothesized
that chronic alcohol consumption might enhance HCC
progression and metastasis.
Tumor angiogenesis, the formation of new blood vessels
from endothelial precursors within tumors, is a prerequis-
ite step for growth and progression of solid malignancies
[6]. Vascular endothelial growth factor (VEGF) is an es-
sential player in tumor angiogenesis and mediates tumor
aggressiveness [7-9]. Monocyte chemotactic protein-1
(MCP-1), a key CC chemokine responsible for traffick-
ing and activation of monocytes/macrophages has been
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recognized as an important angiogenic chemokine [10,11];
it also plays a critical role in solid tumors [12]. Previous
studies indicated that alcohol exposure up-regulated the
expression of VEGF and MCP-1 in other experimental
models [13]. It has also been reported that the expression
of VEGF and MCP-1 was regulated by reactive oxygen
species and NF-ĸB [14,15]. Based on these findings, we
further hypothesized that chronic alcohol consumption
might enhance HCC progression and metastasis through
up-regulating the expression of VEGF/MCP-1, which, in
turn, may be regulated by reactive oxygen species and the
NF-ĸB signaling pathway. We tested this hypothesis by
retrospectively analyzing clinical data, and functional ana-
lysis using experimental models.
Results
Alcohol consumption is associated with advanced TNM
stages, greater vessel invasion and poorer prognosis
We retrospectively surveyed 52 HCC patients, among
which 24 patients consumed alcohol during last 10–40 years
and 28 patients were no-drinkers. No statistical differences
were found in the age, hepatitis B virus (HBV) infection,
presence of cirrhosis, liver function (Child grade), tumor
size, or number of tumors between the alcoholic and non-
alcoholic patients (P >0.05), except for gender (P =0.026;
Table 1). We categorized the alcohol drinkers into two
groups, i.e., low (<35 g/day) and moderate-heavy con-
sumption (35–87.5 g/day and ≥ 87.5 g/day) based on the
average number of drinks they stated. We calculated the
amount of ethanol ingested by assuming 35 g of ethanol
per 100 ml of about 43% v/v spirits. We used the Tumor-
Node-Metastasis (TNM) of International Union Against
Cancer (UICC) system to further classify the stages of
the HCC. Specifically, UICC TNM is comprised of 4
stages (I, II, III, IV) based on growth pattern (single or
multiple), size (≤5 cm or >5 cm), vascular invasion, and
extrahepatic spread. We further analyzed the effects of
alcohol intake on tumor progression and examined the
relationship between the amount alcohol consumption
and the extent of tumor progression. According to the
multivariate binary logistic regression analysis adjusted
for sex, age, HBV infection and liver function (Child
grade), the moderate and high drinkers(35–87.5 g/day
and ≥ 87.5 g/day) had a significantly higher percentage
of advanced tumors (TNM stage III-IV) (OR =22.99;
95% CI: 2.13-248.91; P =0.010), and higher vessel invasion
(OR =21.04; 95% CI: 1.61-275.56, P =0.020) (Table 2).
There was no significant correlation with tumor differenti-
ation (data not shown). However, patients with low alcohol
consumption (<35 g/day) and nondrinkers did not display
statistical difference in TNM stage and vessel invasion.
To further clarify this issue, we included more eligible
HCC patients for the evaluation of correlation between
alcohol consumption and the prognosis. Eighty-two HCC
patients, including 52 cases in first cohort which were con-
firmed by post-operative pathology from 2006 to 2009,
were followed-up for 70 months. Clinical characteristics of
the 82 HCC patients were summarized in Table 3. Forty of
them were nondrinkers and forty two are alcohol users. At
the end of the following-up, 42 patients died. Three alco-
holic and 2 nonalcoholic patients died of liver failure after
surgery. Twenty-four alcoholic and 13 nonalcoholic pa-
tients die due to tumor recurrence and metastasis. Accord-
ing to the multivariate Cox regression analysis, the TNM
stage, liver function (Child grade C) and alcohol consump-
tion were identified as independent prognostic factors for
death due to HCC recurrence. It also showed that the
hazard ratio of alcoholic versus nonalcoholic patients was
4.576 (95% CI: 1.854-11.293, P < 0.01) (Table 4). The over-
all survival rates for nondrinking HCC patients at 12 and
36 months were 75% and 62.5% respectively; however, the
same rates for alcohol drinking HCC patients were 57.15%
and 35.7% respectively. The mortality at 70 months in alco-
holic patients was significantly higher than that of nonalco-
holic patients [64.3% (27/42) vs 37.5% (15/40), P =0.015].
Alcohol consumption significantly shorted life span of pa-
tients (P =0.021) (Figure 1). Thus, HCC patients who were
alcohol drinkers were associated with advanced TNM
stages, higher vessel invasion and poorer prognosis.
Alcohol consumption is associated with enhanced
angiogenesis in HCC tissues
To understand the underlying mechanisms, we first sought
to determine whether alcohol consumption affected tumor
Table 1 Univariate analysis of tumor characteristics and
alcohol consumption in the 52 HCC patients
Variables Never Alcohol consumption n (%)
Ever χ2 P value
Sex Male 21(46.7) 24(53.3) 4.953 0.026a
Female 7(100) 0(0)
Age(yr) ≤50 19(59.4) 13(40.6) 1.023 0.312
>50 9(45) 11(55)
HBV infection Negative 4(45.4) 5(55.6) 0.065 0.799
Positive 24(55.8) 19(44.2)
Cirrhosis Negative 7(53.8) 6(46.2) 0.000 1.000
Positive 21(53.8) 18(46.2)
Child grade A 26(54.2) 22(45.8) __ 0.505*
B 1(33.3) 2(66.7)
C 1(100) 0(0)
Tumor size(cm) ≤5 15(51.7) 14(48.3) 0.119 0.730
>5 13(56.5) 10(43.5)
Number of tumors 1 27(55.1) 22(44.9) 0.119 0.730
≥2 1(33.3) 2(66.7)
aP < 0.05; *exact P.
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angiogenesis. We compared average micrcovessel density
(AMVD) in liver cirrhosis tissue, distant non-cancerous
tissues, HCC tissues of nondrinkers and alcohol users. As
showed in Figure 2A and B, AMVD in HCC tissue was
higher than liver cirrhosis tissue and distant non-cancerous
tissues, indicating higher angiogenesis in tumor (42.6 ± 4.82
vs 27.2 ± 1.48 and 42.6 ± 4.82 vs 16.2 ± 4.43, P < 0.01). More
importantly, AMVD in HCC tissues of alcohol users was
significantly higher than that of nondrinkers.
Alcohol consumption is associated with higher expression
of VEGF, MCP-1 and NF-κB in HCC tissues
To further understand the molecular mechanisms, we
examined the expression of VEGF, MCP-1 and NF-ĸB in
HCC tissues of nondrinkers and alcohol users. As shown
in Figure 2C, VEGF and MCP-1 were expressed in tumor
and hepatic cells. MCP-1 was also present in interstitial
monocytes cells. Higher expression of VEGF and MCP-1
was observed in HCC tissues compared to cirrhosis and
distant non-cancerous liver tissues (Figure 2D). Moreover,
minimum NF-κB was mainly observed in the cytoplasm
Table 2 Odds ratios of TNM stage and vessel invasiveness in relation to different levels of alcohol consumption
TNM I-II TNM III-IV
Control(n = 39) Cases(n = 13) Odds ratio* 95% confidence interval P-Value
NO. % NO. %
Average ethanol intake
0 25 64.2 3 23.1 1.00† x
Low(<35 g/d) 7 17.9 2 15.4 5.81 0.42 80.57 0.190
Moderate(≥35 < 87.5 g/d) & High(≥87.5 g/d) 7 17.9 8 61.5 22.99 2.13 248.91 0.010a
Vessel invasiveness
Control(n = 43) Cases(n = 9) Odds ratio* 95% confidence interval P-Value
NO. % NO. %
Average ethanol intake
0 27 62.8 1 11.1 1.00†
Low(<35 g/d) 8 18.6 1 11.1 2.05 0.09 46.40 0.653
Moderate(≥35 < 87.5 g/d) & High(≥87.5 g/d) 8 18.6 7 77.8 21.04 1.61 275.56 0.020a
*Adjusted for sex, age, HBV infection and liver function (Child grade).
†Reference category.
aP < 0.05.
Table 3 Major clinical characteristics of the 82 HCC
patients
Covariate All cases (n = 82)
Sex Male, n (%) 67(81.7)
Female 15(18.3)
Age (yr) Mean ± SD 50.9 ± 13.1
Alcohol history Never, n (%) 40(48.8)
Ever 42(51.2)
HBV infection Negative, n (%) 11(13.4)
Positive 71(86.6)
Maximal tumor size(cm) Mean ± SD 6.33 ± 4.03
Tumor grade Well differentiated, n (%) 18(22.0)
Moderately differentiated 51(62.2)
Poorly differentiated 13(15.9)
TNM stage I-II, n (%) 50(61.0)
III-IV 32(39.0)
Vessel invasiveness Negative, n (%) 64(78.0)
Positive 18(22.0)
Child grade A, n (%) 64(78.0)
B 14(17.1)
C 4(4.9)
Cirrhosis Negative, n (%) 21(25.6)
Positive 61(74.4)
Table 4 Cox regression analysis of risk factors for death
due to recurrence in 82 HCC patients
Variables HR 95 % confidence interval P-value
Sex 2.469 0.850 7.173 0.097
Age 0.863 0.430 1.732 0.679
HBV infection 0.665 0.250 1.767 0.413
TNM stage 4.089 1.864 8.972 0.000b
Liver function(Child grade) A 0.038
B 2.092 0.846 5.174 0.110
C 4.185 1.162 15.074 0.029a
Alcohol consumption 4.576 1.854 11.293 0.001b
HR: Hazard ratio; Sex: female vs male (HR: 2.469); Age: >50 yr vs ≤50 (HR: 0.863);
HBV infection: positive vs negative (HR: 0.665); TNM: III-IV vs I-II (HR: 4.089); Liver
function (Child grade): B vs A (HR: 2.092), C vs A (HR: 4.185); Alcohol consumption:
alcoholic vs nonalcoholic (HR: 4.576); aP < 0.05; bP < 0.01.
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of hepatocytes in cirrhosis and distant non-cancerous liver
tissues (Figure 2C and E), while in HCC tissues, strong ex-
pression was mainly located in the cytoplasm and nucleus
of cancer cells. In all cases, the intensity for VEGF, MCP-1
and NF-κB immunostaining in the HCC tissues of alcohol
users was much stronger than that of nondrinkers, even
though tissues staining of drinkers and nondrinkers within
the same TNM stage were compared.
Involvement of reactive oxygen species (ROS) and NF-κB
in ethanol-stimulated migration/invasion and tumor
angiogenesis of HepG2 cells
The clinical data from human studies indicated a positive
association between alcohol consumption and enhanced
progression and metastasis of HCC. We therefore sought
to determine the causal relationship in experimental
models. We first evaluated the effects of ethanol on the
migration/invasion of human hepatocarcinoma HepG2
cells. Cell migration was evaluated by wound healing
assay and cell invasion was determined with a Matrigel
Boyden Chamber Assay. As shown in Figure 3A and B,
ethanol exposure (0.2%) significantly increased the migration/
invasion of HepG2 cells. The Matrigel assay indicated
that ethanol exposure increased the invasion of HepG2
cells (Figure 3C and D, *P < 0.05, ** P < 0.01).
We next used a 3D co-culture model to evaluate tumor
angiogenesis. In this system, human umbilical vein endo-
thelial cells (HUVEC) attached to Cytodex beads are able
to form a 3D capillary tube-like network (sprouts), indica-
tive of angiogenesis. As shown in Figure 4A-C, the beads
with sprouts were 36.4% in HUVEC alone group and
48.7% in HUVEC co-cultured with HepG2 cells. Ethanol
exposure (0.2%) significantly increased the percentage of
beads with sprouts (61.1%) in HUVEC/ HepG2 cell co-
culture. These results indicated that ethanol stimulated
tumor angiogenesis. The effects of ethanol were inhibited
by PDTC or C3G. PDTC is a known NF-κB inhibitor and
a metal chelator with some antioxidant property, while
C3G inhibits ROS and mitigate ethanol-induced oxidative
stress. However, the MTT assay showed that C3G and
PDTC (20 μM) did not affect the proliferation of HepG2
cells (data not shown). To test the involvement of ROS
and NF-κB signaling in this process, we demonstrated that
ethanol induced intracellular ROS accumulation and C3G
and PDTC inhibited ethanol-stimulated ROS production
in HepG2 cells (Figure 5A and B). Since NF-κB is also an
important redox-sensitive transcription factor and ethanol
increased intracellular ROS level, we postulated that
ethanol might activate NF-κB signaling. In the canonical
NF-κB pathway, NF-κB activation depends on IκBα phos-
phorylation and degradation. We thus examined the effect
of ethanol on the expression of active p65 NF-κB protein
in HepG2 cells. As show in Figure 5C-5E, ethanol reduced
cytoplasmic p65 NF-κB while increased nuclear p65
NF-κB, indicating that ethanol stimulated nuclear trans-
location of p65 NF-κB. Ethanol also enhanced IκB-α phos-
phorylation and decreased the levels of IκB-α. These
results indicated that ethanol exposure activated NF-κB sig-
naling. Consistently, PDTC reduced IκBα phosphorylation
and p65 NF-κB nuclear translocation, while increased levels
of IκB-α. Similarly, C3G also abolished ethanol-induced
activation NF-κB, suggesting that ethanol-activated NF-κB
signaling was mediated by ROS.
We further examined the effects of ethanol on the tran-
scription of NF-κB using a luciferase reporter. As shown
in Figure 5E, ethanol increased NF-κB transcriptional ac-
tivity, while C3G or PDTC inhibited ethanol-stimulated
NF-κB transcriptional activity. Taken together, ethanol
may stimulate the NF-κB pathway by inducing ROS pro-
duction, which in turn increases migration/invasion and
tumor angiogenesis.
Alcohol enhances liver tumor growth and aggressiveness
in mice
We sought to further confirm our findings in a mouse
xenograft model in which HepG2 cells were implanted
subcutaneously in nude mice. As shown in Figure 6A-C,
ethanol exposure significantly enhanced the rate of tumor
growth; the size/weight of tumor in ethanol-exposed mice
was significantly larger than that in control groups. Etha-
nol exposure also significantly increased tumor metastasis
(Figure 6D), angiogenesis (Figure 6E) and the expression
of VEGF and MCP-1 (Figure 6G).
In addition, PDTC treatment significantly inhibited
ethanol stimulation of tumor growth and metastasis in
Figure 1 Effects of alcohol consumption on the prognosis of
patients with hepatocellular cancer. The overall survival time in
82 HCC patients (40 none-drinkers and 42 alcohol drinkers) during
the period of 2006–2009 was analyzed and presented with Kaplan-Meier
curves. Mean survival time was 27.4 months for non-drinkers and
47.8 months for drinkers, respectively. Alcohol consumption significantly
shorted life span of patients (P= 0.021). The number of patients at risk
was listed below the survival curves.
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mice (Figure 6A-D). Consistent with the observation
made in the in vitro model, PDTC inhibited ethanol-
promoted angiogenesis (Figure 6E and F). PDTC also
reduced the basal expression VEGF and MCP-1 and
blocked ethanol-induced increase in VEGF and MCP-1
expression in liver tumors (Figure 6G).
Discussion
The association between alcohol consumption and the
risk of HCC has been well-established. For example, a
study with a cohort of 19,000 drinkers confirmed that al-
cohol enhances the risk of upper gastrointestinal tumors
including liver cancer [16]. Rehm et al. [17] reported
that RRs of liver cancer for low (0–39.99 g/d), hazardous
(40–59.99 g/d) and harmful (60+ g/d) levels of alcohol
consumption compared to never drinkers are 1.45, 3.03,
and 3.60 respectively. Hennig et al. suggested the close
association between alcohol consumption and HCC pro-
gression in vitro [18]. Huang et al. also confirmed that
ethanol consumption induces hepatocellular carcinoma
cell metastasis by changing the extracellular matrix
in vitro and this ability was reduced by food components
such as pterostilbene and curcumin analogues [19]. In a
mouse model of hepatocaricinogenesis, Brandon-Warner
et al. found that chronic ethanol feeding accelerated hepa-
tocellular carcinoma progression in male mice [20]. In our
study, we demonstrate a positive correlation between alco-
hol consumption and enhanced HCC progression, even
Figure 2 Effects of chronic alcohol consumption on the expression of CD31, VEGF, MCP-1 and NF-kB in HCC patients. (A)
Immunohistochemical analysis of new blood vessels with anti-CD31 staining in different liver tissues. a: Liver cirrhosis; b: Distant non-cancerous
liver tissues in HCC patients; c: HCC tissues of no-alcohol drinking patients; d: HCC tissues of alcohol-drinking patients; a-d: (Bar: 200 μm). The
brown staining indicates the presence of microvessels. (B) Quantitative analysis of average microvessel density (AMVD, the number of
microvessels per mm2 area) indicated that alcohol consumption significantly increased the number of new blood vessels (61.0 ± 6.78 in alcohol drinking
patient vs 42.6 ± 4.82 in no-alcohol drinking patients, ** P < 0.01). (C) Immunohistochemical analysis of VEGF, MCP-1 and NF-κBp65 in liver tissues and
HCC. (Bar: 100 μm). Arrows indicate NF-kBp65+ brown stain, which mainly found in the nuclei of tumor cells. (D) Quantitative analysis of VEGF, MCP-1
was determined by integral optical density. (E) Quantitative analysis of NF-κBp65 immunohistochemistry, as given by the nuclear-to-cytoplasmic ratio of
NF-κBp65 positivity, n = 3.
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though the cohort of this study is relatively small (82 pa-
tients). Donato et al. showed that heavy alcohol consump-
tion (>80 g of ethanol per day) is associated with the
increased risk of HCC compared to non-drinkers [21].
However, our data indicated that the moderate and heavy
drinking (35–87.5 g/day and ≥ 87.5 g/day) was associated
with enhanced HCC progression. There are many factors
underlying this discrepancy. A larger cohort may be
needed to provide more definite conclusion. In our co-
hort, the number of male patients is much larger than that
of female; this is consistent with the epidemiological find-
ings that males are about two to four times more likely to
develop HCC than females [22]. In future study, analysis
of a larger cohort may be necessary to evaluate the inter-
action between alcohol consumption and other risk fac-
tors, such as Hepatitis B virus or hepatitis C virus which
are known risk factors for the development of liver cancer
due to chronic liver inflammation [23]. Nevertheless, our
clinical data provides the necessary foundation for our
further experimental studies.
HCC is a vascular-dependent malignant tumor; an in-
crease in tumor dimension above 0.5 mm will induce the
proliferation of vascular endothelial cells and angiogenesis
which is essential for tumor growth and metastatic dis-
semination [24]. Our previous study and results from
others showed that alcohol may promote tumor angiogen-
esis in animals [13,25,26]. The current study for the first
time demonstrates that alcohol consumption is closely
associated with a higher micrcovessel density in HCC tis-
sues, which implied that alcohol potentially enhances
tumor angiogenesis in HCC patients. This interpretation
is further supported by experimental data. For example,
alcohol increases micrcovessel density in tumor tissues in
a HCC xenograft model . Furthermore, we show that alco-
hol can stimulate tumor angiogenesis in a 3D model of
tumor/endothelial cell co-culture system. Together, these
results indicate that enhanced angiogenesis is a potential
mechanism for alcohol-promoted progression of HCC.
VEGF and MCP-1 are key mediators for tumor angio-
genesis and metastasis [27,28]. VEGF, as a pro-angiogenic
factor, plays an essential role in the process of angiogen-
esis, including microvascular permeability, endothelial cell
proliferation and tumor cell migration [29,30]. VEGF-
positive tumors in HCC patients had much greater invasive
potential and intrahepatic metastasis than VEGF-negative
tumors [31]. Tan et al. [25] showed that alcohol increased
Figure 3 Effects of ethanol on the migration/invasion of HepG2 cells in vitro. (A) The migration of HepG2 cells was analyzed by the wound
healing assay as described in the Materials and methods. HepG2 cells were exposed to ethanol (0.2%) with/without PDTC (20 μM) for 24 hours.
Representative images of wound healing at 0 and 24 hours are shown. (B) Quantification of the migration of HepG2 cells. (C) The invasion of
HepG2 cells was analyzed by a matrigel invasion assay. HepG2 cells were plated into the upper compartments of the matrigel invasion chambers
and exposed to ethanol (0.2%) with/without PDTC (20 μM) or C3G (20 μM) for 48 hours. Images of cells migrating through the chambers were
shown. (D) The cells migrated through the chamber were quantified. *P <0.05, **P <0.01, n = 3.
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the expression of VEGF in melanoma xenograft model.
MCP-1 is also a potent pro-angiogenic chemokine which
is associated with many malignant tumors progression by
recruitment of macrophages and induction of angiogen-
esis [32,33]. In both ectopic and orthotropic xenograft
models, the MVD was significantly increased in tumors
over-expressing MCP-1 [34]. We have previously demon-
strated that alcohol can stimulate the expression of MCP-
1 in breast cancer cells, which caused an enhanced angio-
genesis [13]. That a higher expression level of VEGF and
MCP-1 is observed in HCC patients of alcohol-drinkers
supports a role of VEGF and MCP-1 in alcohol promotion
of HCC.
NF-κB plays a key role in tumorigenesis/progression
and also regulates the expression of VEGF and MCP-1
[35]. Consistently, we show that the expression of NF-κB
is higher in alcohol-drinkers HCC patients than in that
in non-drinkers. Furthermore, PDTC, an inhibitor of
NF-κB and an antioxidant, attenuates alcohol-induced
VEGF and MCP-1 expression in mice, supporting that
ethanol-stimulated expression of VEGF/MCP-1 is medi-
ated by NF-κB signaling.
NF-κB activity is regulated by reactive oxygen species
(ROS) [36]. We have previously shown that ethanol can
induce intracellular ROS accumulation in breast cancer
cells [37,38]. ROS plays an important role in carcinogen-
esis as a result of oxidative stress including oxidative
injury, inflammation, and lipid peroxidation [39]. C3G, a
potent antioxidant, has been shown to effectively inhibit
ROS and mitigate ethanol-induced oxidative stress [38].
We confirm here that ethanol causes the accumulation
of intracellular ROS in HepG2 cells and C3G scavenges
ethanol-induced ROS. More importantly, C3G blocks
ethanol-stimulated NF-κB promoter activities, suggesting
that ethanol-induced ROS mediated NF-κB transcriptional
activity. At cellular level, both PDTC and C3G effectively
inhibit ethanol-induced migration/invasion of HepG2
cells and abolish the pro-angiogenic effect of ethanol in
a 3-D model of tumor/endothelial cell co-culture. They
also attenuate ethanol-induced tumor growth and me-
tastasis in mice.
Conclusions
In conclusion, our results indicate that alcohol con-
sumption induces intracellular ROS accumulation which
results in the activation of NF-κB and up-regulation of
VEGF and MCP-1. VEGF and MCP-1 promotes tumor
angiogenesis which may mediate ethanol-stimulated pro-
gression/metastasis of HCC (Figure 7).
Figure 4 Effects of ethanol on tumor angiogenesis in a 3-D model in vitro. Tumor angiogenesis was analyzed using a 3-D co-culture system
as described in Materials and methods. (A) Representative images of sprouts from HUVEC cells with bead under various culture conditions are
shown. (B) HUVEC and HepG2 co-cultures were treated with ethanol (0.2%) with/without PDTC (20 μM). The angiogenesis which was indicated
by the growth of endothelial sprouts was measured. (C) HUVEC and HepG2 co-cultures were treated with ethanol (0.2%) with/without C3G
(20 μM). The angiogenesis which was indicated by the growth of endothelial sprouts was measured. **P < 0.01, n = 3.
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Materials and methods
Drugs and reagents
Ethanol, fibrinogen, aprotinin, thrombin and Pyrrolidine
dithiocarbamate (PDTC) were purchased from Sigma
Chemical Co. (St. Louis, MO). Cyanidin-3-glucoside
(C3G) was prepared as previously described [38]. Anti-
MCP1 and anti-VEGF antibodies were obtained from
Abcam (Cambridge, MA). Anti-NF-κB p65, IκBα, p-IκBα
and anti-LMNB1 antibodies were purchased from Protein
Tech Group (Chicago, IL, USA). Anti-β-actin was ob-
tained from Cell signaling Technology (Danvers, MA).
Anti-CD31 antibody was obtained from BD Pharmingen
(San Diego, CA). Reactive oxygen species detection
reagents were obtained from Invitrogen Molecular
Probes (Eugene, OR). MTT assay kit was purchased
from Roche Molecular Biochemicals (Indianapolis,
Figure 5 Effects of ethanol on intracellular ROS and the activation of NF-kB. (A) HepG2 cells were treated with ethanol (0.2%) with/without
PTDC or C3G for 0.5 hours. Intracellular ROS was detected by flow cytometry as described in Materials and methods. (B) The relative levels
of intracellular ROS were quantified. **P < 0.01. (C-D) HepG2 cells were treated with ethanol (0.2%) with/without PTDC or C3G for 2 hours.
Expression of IkBα, p-IkBα and NF-kB p65 in cytoplasm and nuclei was analyzed by immunoblotting (left panel). The relative expression
levels were quantified with a densitometry (right panel). *P < 0.05, **P < 0.01. (E) NF-kB activity was detected by the luciferase reporter gene
assay. **P < 0.01, n = 3.
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IN). Matrigel Invasion Chambers were purchased
from BD Biosciences (Bedford, MA). Cytodex 3 beads
were purchased from Amersham Pharmacia Biotech
(Piscataway, NJ).
Clinical patient data
The medical records of 52 HCC patients, admitted to
first hospital of Anhui Medical University, were retro-
spectively analyzed between January and December 2009
Figure 6 Effects of ethanol on tumor development in a xenograft model. (A) HepG2 cells were implanted subcutaneously in nude mice.
The mice were exposed to ethanol in drinking water (0 or 2% ethanol). Mice were injected with PDTC (0 or 100 mg/kg). The size of tumor was
measured every other day. (B) At the end of experiments, tumors were removed for subsequent analyses. A representative image shows tumors
from control and ethanol-exposed mice with/without PDTC treatment. (C) Tumor weight was determined and presented as the means ± SD
(n = 12). (D) Tumor metastases in the lungs were analyzed. A representative microphotograph shows metastatic carcinoma nodes in the lungs of
ethanol-exposed mice (arrow, top panel; Bar: 100 μm). The percentage of mice which were positive for lung metastasis was quantified (bottom
panel). (E) Microvessels in tumor tissues were detected by CD31 immunohistochemistry (Bar: 50 μm). a: water control, b: water plus PDTC, c: 2%
ethanol, d: 2% ethanol plus PDTC. (F) AVMD was determined as described in Figure 2. (G) VEGF and MCP-1 in tumor tissues were detected by
IHC (Bar: 100 μm). *P < 0.05, **P < 0.01, n = 3.
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(Table 1). Patients were asymptomatic at admission and
diagnosed by examining the liver with computed tomog-
raphy. All patients were performed anatomical liver re-
section. HCC and cirrhosis was confirmed by pathology.
Cirrhosis developed in 76.9% (39 of 52) of patients.
Forty-three patients (82.7%) were infected with hepatitis
B virus. A series of demographic and clinical data were
collected including alcohol consumption, tumor charac-
teristics and pathologic stages. Survival and follow-up
data were acquired by telephone interviews. With the
approval of the first affiliated hospital of Anhui Medical
University of Human Studies Committee, formalin-fixed
paraffin-embedded tumor materials of 52 HCC patients
were obtained. The histological sections of all cases were
evaluated by oncopathologists.
Cell culture and ethanol exposure
Human hepatoma cell line HepG2 and mouse embry-
onic fibroblast cell line NIH3T3 were provided by the
Institute of Cell and Biochemistry, Chinese Academy of
Sciences (Shanghai, China) and maintained in Dulbecco’s
modified Eagle’s medium(DMEM) containing 10% fetal
bovine serum (FBS), penicillin (100 U/ml)/streptomycin
(100 U/ml), at 37°C with 5% CO2. The original primary
human umbilical vein endothelial cells (HUVECs) were
isolated from human umbilical veins by using collage-
nase (Roche Diagnostics, Switzerland) as previously de-
scribed [40], and maintained on 0.2% gelatin coated in
EGM-2 medium (Lonza, Walkersville, MD, USA) which
consists of endothelial cell basal medium (EBM-2) with
10% FBS and other additives. Alcohol was added to the
medium at concentrations of 0.2% v/v ethanol. Cell cul-
ture plates were placed on a rack inside a plastic con-
tainer sealed with a tight-fitting lid. At the bottom of
each container, there was a 200-ml water bath, which
contained the same concentration of ethanol as in the
cultural media. The containers were placed in a humidi-
fied environment and maintained at 37°C with 5% CO2.
Animals and ethanol administration
Male nude mice (4–5 weeks old, 15–20 g, n = 12/group)
were purchased from the Animal Center, Chinese Acad-
emy of Sciences. The ethanol was administrated in drink-
ing water as described previously [13]. Briefly, mice were
given 2% ethanol in drinking water for a 12 h period dur-
ing the night and then replaced with water without ethanol
at day time. The mice in the control group were provided
with regular drinking water only. All procedures were car-
ried out according to the guidelines of the Animal Welfare
Act approved by the Institutional Animal Care and Use
Committee of Anhui Medical University. The blood etha-
nol concentration (BEC) was determined at 6:00 a.m. using
an Analox AM1 Alcohol Analyzer (Analox Instruments,
Lunenburg, MA) as previously described [41]. The BEC
was 56.18 ± 11.6 mg/dl.
Mouse model of tumor xenograft
HepG2 human hepatoma cells were implanted subcutane-
ously in nude mice according to the previous study [13].
Briefly, three days after ethanol exposure, HepG2 cells
(1 × 106 in 100 μl PBS) were injected subcutaneously into
mice using a 23-gauge needle. The mice were continually
provided with 2% ethanol in drinking water or regular
drinking water without ethanol. The size of the tumors
was monitored every 2 days; two perpendicular dimen-
sions of tumors were measured with a dial caliper. The
volume was calculated based on the formula: V = 0.25 a ×
b 2; a is the longest and b is the shortest dimension. At the
end of experiment, animals were killed and the tumors
were removed. Some of the tumor tissues were fixed with
10% neutral formalin for and immunohistochemical stud-
ies. To evaluate the effect of PDTC on ethanol-mediated
tumor growth, PDTC [100 mg/kg in 100 μl of Dimethyl
sulfoxide (DMSO)] or DMSO alone was injected intraper-
itoneally 2 days following ethanol exposure. PDTC was
administered every three days. The dosage of PDTC was
selected based on previous studies [42]. There were seven
mice for each treatment group.
Histology and immunohistochemistry
Immunohistochemical (IHC) procedure was performed
generally as described [43]. Briefly, Five-micrometer-thick
Figure 7 Proposed working model for the role of the NF-kB
signaling pathway in the regulation of ethanol-enhanced the
progression of HCC. (1) ROS induced by alcohol mediated
activation of the NF-kB pathway. This effect can be abolished by
C3G or PDTC. (2) Nuclear translocation of NF-kB via phosphorylation
by the IkB kinase, which then binds target DNA that regulates VEGF
and MCP-1 gene expression. Ultimately, the changes stimulated by
alcohol enhance angiogenesis, tumor growth and metastasis.
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sections were cut and deparaffinaged in xylene prior to re-
hydration using gradient alcohol. For antigen retrieval,
sections were treated with citrate buffer saline (pH 6.0) for
15 minutes at 95°C in a microwave oven. After blocking
with 10% normal goat serum for 30 minutes at room
temperature, the sections were incubated with primary
antibodies: anti-MCP-1 (1:100), anti-VEGF (1:150), anti-
NF-κBp65 (1:100), or anti-CD31 (1:100) overnight at 4°C.
Following incubation, sections were washed with phos-
phate buffered solution and incubated with horseradish
peroxidase-conjugated goat anti-rabbit IgG for 1 h at
room temperature. The avidin-biotin complex was added
and the enzyme activity was visualized with 3, 3’-diamino-
benzidine (DAB). Negative controls were prepared using
PBS instead of the primary antibody. The average micro-
vessel density (AMVD) of ten selected microscopic fields
was calculated and expressed as the number of microves-
sels per mm2 area, according to previous report [44]. The
integral optical density (IOD) of the stained sections was
measured with a computer-assisted image-processing and
analytical system. NF-κBp65 expression was analyzed by
counting NF-κBp65-positive hepatocytes within 50 HPF
with discrimination of the intracellular distribution serv-
ing as an indicator of NF-κB nuclear translocation. The
nuclear-to-cytoplasmic ratio was calculated by dividing
the number of cells with nuclear NF-κBp65 positivity by
the number of cytoplasmic NF-κBp65 positive cells.
Analysis of experimental lung metastasis
After 5 weeks of ethanol exposure, mice in four groups
(n = 22 for each group) were sacrificed. The fresh lung
samples were harvested and fixed with 10% formalin
for histopathology analysis. Tissues were paraffin-embedded
and sectioned at a thickness of 5 μm. The sections were
stained with hematoxylin–eosin (H&E) and then exam-
ined under the microscope to evaluate the morphological
changes of metastasis tumors.
Detection of intracellular reactive oxygen species
Intracellular reactive oxygen species (ROS) levels were
measured using the fluorescent dye CM-H2DCFDA
(Invitrogen Corporation, Carlsbad, CA) as previously de-
scribed [45]. Briefly, HepG2 cells were trypsinized and
seeded onto 6-well plates pretreated with/without C3G
(20 μM) or PDTC (20 μM) for 0.5 hours before ethanol
exposure. After the treatment, cells were washed with
cold PBS and incubated with 5 μM CM-H2DCFDA for
30 min, followed by several additional washes with cold
PBS. Cells were trypsinized and transferred into poly-
styrene round-bottom tubes; intracellular ROS levels
were measured with a flow cytometer (FACScalibur, BD
Biosciences, San Jose, CA) at an emission wavelength of
525 nm.
Preparation of protein extracts
Cells (5 × 106) were harvested, resuspended in 50 μl of
lysis buffer A (10 mM Hepes, 10 mM KCl, 0.1 mM
MgCl2, 0.1 mM EDTA, 2 μg/ml leupeptin, 2 μg/ml pep-
statin, 0.5 mM PMSF, pH 7.9), incubated on ice for
10 min and centrifuged for 10 min at 800 × g at 4°C.
The supernatant was treated as the cytoplasmic fraction.
The pellet (nuclei) was washed with buffer A and nu-
clear proteins were extracted in presence of 50 μl of buf-
fer B (10 mM Hepes, 400 mM NaCl, 1.5 mM MgCl2,
0.1 mM EDTA, 2 μg/ml leupeptin, 2 μg/ml pepstatin,
0.5 mM PMSF, pH 7.9). Protein concentration was deter-
mined using a BCA protein assay kit (Pierce, Rockford, IL)
according to the manufacturer's instructions.
Western blotting analysis
SDS–PAGE and Western blotting were performed ac-
cording to standard procedures. Briefly, protein samples
(10 μg) were subjected to electrophoresis on 4-12%
SDS-polyacrylamide gradient gels and transferred to a
PVDF membrane. After overnight blocking with 2%
BSA in TBS-Tween 0.1%, the membranes were probed
with anti-NF-κB p65 (1:1000), IκBα (1:500), p-IκBα
(1:1000), β-actin (1:1000) or anti-LMNB1 (1:1000) anti-
bodies overnight at 4°C. Anti-rabbit HPR conjugated
antibody was used as a secondary antibody followed by
enhanced chemiluminescence reaction. All Western blot-
ting were repeated three times.
Luciferase reporter gene assay
NIH3T3 cells were trypsinized and seeded in 96-well
plates at an initial density of 2 × 104 cells/well in DMEM
containing 10% FBS at 37°C with 5% CO2 overnight.
The cells at 50%–80% confluence were performed with
6 μg of pGL4.32 [luc2P/NF-κB-RE/Hygro] plasmid (Pro-
mega) transfected with Lipofectamine™ 2000 Transfection
Reagent (Invitrogen) for normalizing transfection efficiency.
The non-transfected cells were used as blank group. At
48 hours after transfection, cells were collected and resus-
pended in passive lysis buffer (Promega). Then the cells
were exposed with/without ethanol in the presence or ab-
sence of PDTC or C3G. After incubation for 2 h, Lucifer-
ase activity was evaluated with a dual luciferase assay
system (GloMax 96 Microplate Luminometer, Promega)
according to manufacturers.
Cell proliferation assay
The MTT assay was employed to determine the number
of viable cells in culture. Briefly, the cells were plated
into 96-well plates and exposed to ethanol with/without
C3G (20 μM) or PDTC (20 μM) for indicated times.
After the treatment, 10 μl of MTT reagent was added
into each well and the plates were incubated at 37°C for
4 h. After lightly vortexing the plate on an orbital shaker,
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the spectrophotometric absorbance was read on a micro-
plate reader (Bio Rad Model 3550-UV) at 595 nm. Each
individual experiment was performed at least three times.
Wound healing migration assay
Wound healing assay was carried out to determine the
cell migration ability of tumor cells. The wound healing
migration assay was performed as described previously
[46]. Briefly, HepG2 cells were plated on 6-well plates and
grown to 80% - 90% confluence. Sterilized one-milliliter
pipette tip was used to generate a wound across the cell
monolayer, and the plates were washed with PBS. The
cells were then treated with ethanol (0.2% v/v) in the pres-
ence or absence of PDTC (20 μM) for 24 h. Cells migrated
into the wounded area or protruded from the border of
the wound were visualized and photographed under the
inverted microscope (Olympus, Japan).
Cell invasion assay
Cell invasion was performed in BD Bio Coat Matrigel
Invasion chambers (BD Biosciences, Clontech; Bedford,
MA, USA) with a porous polycarbonate membrane (8.0
micron pore size) as previously described [47]. Briefly,
HepG2 cells (5 × 105) were seeded onto upper chambers
and treated with ethanol in the presence or absence of
C3G or PDTC(20 μM). The lower compartment of the
chamber was filled with medium containing 2%BSA
served as chemoattractants for the cells. The chambers
were cultured at 37°C in 5% CO2 for 48 h to allow
tumor cell invasion through the matrix. Migrated cells
were fixed with 100% methanol and stained with Giemsa
for invasion assay. The filters were photographed and
the cells were counted. The invasion assay was repeated
in five separate experiments, with control and experi-
mental groups performed in parallel.
Three-dimensional (3D) endothelial cell and tumor
co-culture system
3-D model of endothelial cell and tumor cell co-culture
system was performed to investigate the effect of ethanol
on tumor angiogenesis as described previously [13]. In
this model, endothelial cells were induced to form a 3D
capillary tube-like network on a fibrin gel bead system in
the presence or absence of tumor cells. In brief, HUVEC
or HepG2 cells (1 × 106) were trypsinized and mixed
with Cytodex beads (3 × 103) in DMEM medium. After
incubation, the mixtures of cells/Cytodex beads were re-
suspended in medium containing 2.5 mg/ml fibrinogen
and 0.15 U/ml aprotinin. A volume of 0.5 ml fibrinogen/
bead solution was added to 24-well cell culture plates
that were pre-coated with 0.625 U of thrombin. After
coagulation, the resulting fibrin gels contained endothe-
lial cells (HUVEC or HepG2) adhering to the beads. For
co-culture of endothelial cells/tumor cells, the medium
collected from HepG2 cells with/without ethanol in pres-
ence or absence of C3G or PDTC were added on top of
the fibrin gels. The culture media was changed every two
days. At different time points, cell morphogenesis was ob-
served using an inverted phase-contrast microscope. Tube
formation was quantified by counting branches from four
representative fields per replicate. These experiments were
performed in triplicate.
Statistical analysis
Data were presented as means ± standard deviations and
analyzed by ANOVA, followed by Student-Newman-Keuls
test. The correlations between alcohol consumption and
clinicopathological features were analyzed by Pearson
Chi-square test. Multivariable binary logistic regression
was carried out to estimate odds ratio (OR) with its 95%
confidence intervals (CI) in order to assess the risk factors
for HCC aggressiveness. The multivariate Cox propor-
tional hazards regression model was employed to estimate
the prognostic factors associated with HCC recurrence.
For the survival analysis after surgical resection, the data
were processed using the Kaplan-Meier method and were
compared using the log-rank test. Statistical analysis was
conducted with SPSS 16.0 (IBM Corporation, Chicago, IL,
United States). A value of P < 0.05 was considered statisti-
cally significant.
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